This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
April 26, 2021
CARISMA Therapeutics Establishes Collaboration with Leading Cell Therapy Expert to Explore and Develop Allogeneic CAR-Macrophages
April 26, 2021
Oncopeptides publishes the 2020 Annual Report
April 26, 2021
Annual General Meeting in Oncopeptides AB (publ)
April 20, 2021
BONESUPPORT awarded Synthetic Implantable Products agreement with Premier
April 20, 2021
Pulmonx to Report First Quarter 2021 Financial Results on May 4, 2021
April 20, 2021
Nordic Nanovector ASA – Share capital increase registered
April 20, 2021
Vicore Pharma to host Key Opinion Leader webinar on C21 for the treatment of COVID-19
April 16, 2021
Oncopeptides submits application for conditional marketing authorization of melflufen in the EU
April 15, 2021
Vicore Pharma publishes the Annual Report for 2020
April 13, 2021
BONESUPPORT Holding AB publishes Annual Report 2020